NEC OncoImmunity AS
🇳🇴Norway
- Country
- 🇳🇴Norway
- Ownership
- Subsidiary
- Established
- 2014-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.oncoimmunity.com
NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors
Phase 1
Recruiting
- Conditions
- Solid Tumors, Adult
- Interventions
- Biological: NECVAX-NEO1
- First Posted Date
- 2022-04-29
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- NEC OncoImmunity AS
- Target Recruit Count
- 15
- Registration Number
- NCT05354323
- Locations
- 🇱🇹
National Cancer Institute, Vilnius, Lithuania
🇱🇹Vilnius University Hospital Santaros Clinics, Vilnius, Lithuania
🇱🇹Kaunas University Hospital, Kaunas, Lithuania
© Copyright 2025. All Rights Reserved by MedPath